TAVIST
LOE ApproachingNDAORALSYRUP
Approved
Jun 1985
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TAVIST is an oral syrup antihistamine approved in 1985 for allergy treatment, likely containing clemastine fumarate or a similar first-generation H1-receptor antagonist. It works by competitively blocking histamine receptors to reduce allergic symptoms including itching, edema, and smooth muscle constriction. The drug exhibits anticholinergic and sedative properties typical of its class.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), indicating resource focus has likely shifted to newer pipeline assets or cost-management initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TAVIST offers limited growth trajectory; this is a maintenance role on a mature, declining brand with minimal attached headcount. Career professionals should view TAVIST roles as stepping stones toward pipeline assets, product portfolio optimization, or generic/OTC transition management.
Brand ManagerPharmacovigilance Specialist
Worked on TAVIST at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.